Lung Cancer Drug Crizotinib Shows Promise
27 Oct 2010 ... An experimental drug is showing great promise as a targeted treatment for lung cancer patients with a specific genetic abnormality.
Pfizer's lung cancer drug crizotinib shows early promise ...
28 Oct 2010 ... According to a study published in the New England Journal of Medicine, Pfizer's cancer drug crizoinib was able to treat non-small cell lung ...
BBC News - Drug reduces lung cancer deaths, Swiss study finds
24 Jan 2011 ... Lung cancer drug 'extends life' 08 JUNE 2010, HEALTH; Tamoxifen 19 MAY 2000, MEDICAL NOTES; Way to 'boost' breast cancer drug 23 FEBRUARY ...
New lung cancer drug shows dramatic results for shrinking tumors ...
23 Jun 2010 ... Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial being offered. The new drug, crizotinib, ...
Trial of Lung Cancer Drug Curtailed Over Blood Clot Concerns ...
2 Feb 2011 ... Drugmakers Eli Lilly & Co. and Bristol-Myers Squibb Co. have stopped enrolling patients in a clinical trial of an experimental lung cancer ...
New targeted lung cancer drug produces 'dramatic' symptom improvement
27 Oct 2010 ... A clinical trial of a potential new targeted treatment drug has provided powerful evidence that it can halt or reverse the growth of lung ...
Lung Cancer Drug Speeds Through Clinical Trials | LiveScience
27 Oct 2010 ... A new drug called crizotinib shows strong promise for patients with a metastatic form of lung cancer.
Crizotinib, Lung Cancer Drug, Shows Big Promise In Early Tests
5 Jun 2010 ... CHICAGO ??? It's way too soon to declare success, but an experimental drug for lung cancer patients with a certain gene showed extraordinary ...
GNN - Why a Lung Cancer Drug Works So Well for Some People
29 Apr 2004 ... Two groups of researchers have discovered why the lung cancer drug Iressa works so well when it does. Patients who respond to Iressa have ...
Experimental Lung Cancer Drug Shows Promise in Early Tests ...
5 Jun 2010 ... Experimental Lung Cancer Drug Shows Promise in Early Tests, Doctors are reporting unusually high success rates from early tests of an ...